10. Europe Transcatheter Tricuspid Valve Intervention Market: An Analysis (2021-2030)
10.1 Europe Transcatheter Tricuspid Valve Intervention Market: Size and Forecast (2021-2030), By Value
10.2 Europe Transcatheter Tricuspid Valve Intervention Market: Prominent Companies
10.3 Market Segmentation By Intervention Type (Tricuspid Valve Repair and Tricuspid Valve Replacement)
10.4 Market Segmentation By Disease Type (Tricuspid Regurgitation and Tricuspid Stenosis)
10.5 Market Segmentation By End User (Hospitals, Ambulatory Surgical Centers, Others)
10.6 Europe Transcatheter Tricuspid Valve Intervention Market: Country Analysis
10.7 Market Opportunity Chart of Europe Transcatheter Tricuspid Valve Intervention Market - By Country, By Value (Year-2030)
10.8 Competitive Scenario of Europe Transcatheter Tricuspid Valve Intervention Market - By Country (2025 & 2030)
10.9 Germany Transcatheter Tricuspid Valve Intervention Market: Size and Forecast (2021-2030)
10.10 Germany Transcatheter Tricuspid Valve Intervention Market Segmentation By Intervention Type, By Disease Type, By End User (2021-2030)
10.11 United Kingdom Transcatheter Tricuspid Valve Intervention Market: Size and Forecast (2021-2030)
10.12 United Kingdom Transcatheter Tricuspid Valve Intervention Market Segmentation By Intervention Type, By Disease Type, By End User (2021-2030)
10.13 Italy Transcatheter Tricuspid Valve Intervention Market: Size and Forecast (2021-2030)
10.14 Italy Transcatheter Tricuspid Valve Intervention Market Segmentation By Intervention Type, By Disease Type, By End User (2021-2030)
10.15 France Transcatheter Tricuspid Valve Intervention Market: Size and Forecast (2021-2030)
10.16 France Transcatheter Tricuspid Valve Intervention Market Segmentation By Intervention Type, By Disease Type, By End User (2021-2030)
List of Figures
Figure 1: Global Transcatheter Tricuspid Valve Intervention Market Size, By Value, 2021-2030 (USD Million)
Figure 2: Global Expected Number of Transcatheter Tricuspid Valve Intervention (Repair and Replacement) Procedures (In thousands), Year 2020 - 2030E
Figure 3: Global Aged Population (Above 65), 2015-20 (% of total Population)
Figure 4: Global Aged Population (Above 65), By Country, 2020 (% of total Population)
Figure 5: Current Healthcare Expenditure (% Share of GDP), By Selected Country, 2014-2018 (In %)
Figure 6: Global Transcatheter Tricuspid Valve Intervention Market - By Intervention Type Market Share, 2025 & 2030
Figure 7: Global Transcatheter Tricuspid Valve Intervention Market - By Tricuspid Valve Repair, By Value (USD Million), 2021-2030
Figure 8: Global Transcatheter Tricuspid Valve Intervention Market - By Tricuspid Valve Replacement, By Value (USD Million), 2021-2030
Figure 9: Global Transcatheter Tricuspid Valve Intervention Market - By Disease Type Market Share, 2025 & 2030
Figure 10: Global Transcatheter Tricuspid Valve Intervention Market - By Tricuspid Regurgitation, By Value (USD Million), 2021-2030
Figure 11: Global Transcatheter Tricuspid Valve Intervention Market - By Tricuspid Stenosis, By Value (USD Million), 2021-2030
Figure 12: Global Transcatheter Tricuspid Valve Intervention Market - By End User Market Share, 2025 & 2030
Figure 13: Global Transcatheter Tricuspid Valve Intervention Market - By Hospitals, By Value (USD Million), 2021-2030
Figure 14: Global Transcatheter Tricuspid Valve Intervention Market - By Ambulatory Surgery Centers, By Value (USD Million), 2021-2030
Figure 15: Global Transcatheter Tricuspid Valve Intervention Market - By Others, By Value (USD Million), 2021-2030
Figure 16: Global Transcatheter Tricuspid Valve Intervention Market - By Region Market Share, 2025 & 2030
Figure 17: North America Transcatheter Tricuspid Valve Intervention Market Size, By Value, 2021-2030 (USD Million)
Figure 18: North America Current health expenditure per capita (current USD), 2014-18
Figure 19: North America Population ages 65 and above (% of total Population), 2016-20
Figure 20: North America Diabetes Prevalence, By Country, 2020 (% of Population Aged 20 to 79)
Figure 21: North America Transcatheter Tricuspid Valve Intervention Market - By Intervention Type, By Value (USD Million), 2021-2030
Figure 22: North America Transcatheter Tricuspid Valve Intervention Market - By Disease Type, By Value (USD Million), 2021-2030
Figure 23: North America Transcatheter Tricuspid Valve Intervention Market - By End User, By Value (USD Million), 2021-2030
Figure 24: Market Opportunity Chart of North America Transcatheter Tricuspid Valve Intervention Market - By Country, By Value (Year-2030)
Figure 25: North America Transcatheter Tricuspid Valve Intervention Market - By Country Market Share, 2025 & 2030
Figure 26: United States Transcatheter Tricuspid Valve Intervention Market Size, By Value, 2021-2030 (USD Million)
Figure 27: United States Current health expenditure per capita (current USD), 2014-18
Figure 28: United States Population aged 65 and above (% of total Population), 2016-20
Figure 29: Percent of adults aged 18+ with obesity crude Prevalence in the U.S., 2014-218
Figure 30: United States Transcatheter Tricuspid Valve Intervention Market - By Intervention Type, By Value (USD Million), 2021-2030
Figure 31: United States Transcatheter Tricuspid Valve Intervention Market - By Disease Type, By Value (USD Million), 2021-2030
Figure 32: United States Transcatheter Tricuspid Valve Intervention Market - By End User, By Value (USD Million), 2021-2030
Figure 33: Canada Transcatheter Tricuspid Valve Intervention Market Size, By Value, 2021-2030 (USD Million)
Figure 34: Canada Current health expenditure per capita (current USD), 2014-18
Figure 35: Canada Population aged 65 and above (% of total Population), 2016-20
Figure 36: Canada Transcatheter Tricuspid Valve Intervention Market - By Intervention Type, By Value (USD Million), 2021-2030
Figure 37: Canada Transcatheter Tricuspid Valve Intervention Market - By Disease Type, By Value (USD Million), 2021-2030
Figure 38: Canada Transcatheter Tricuspid Valve Intervention Market - By End User, By Value (USD Million), 2021-2030
Figure 39: Europe Transcatheter Tricuspid Valve Intervention Market Size, By Value, 2025-2030 (USD Million)
Figure 40: Europe Population ages 65 and above (% of total Population), 2016-20
Figure 41: European Countries Population ages 65 and above (% of total Population), 2020
Figure 42: Europe Current health expenditure per capita (current USD), 2014-18
Figure 43: Europe Diabetes Prevalence, By Country, 2020 (% of Population Aged 20 to 79)
Figure 44: Europe Transcatheter Tricuspid Valve Intervention Market - By Intervention Type, By Value (USD Million), 2021-2030
Figure 45: Europe Transcatheter Tricuspid Valve Intervention Market - By Disease Type, By Value (USD Million), 2021-2030
Figure 46: Europe Transcatheter Tricuspid Valve Intervention Market - By End User, By Value (USD Million), 2021-2030
Figure 47: Market Opportunity Chart of Europe Transcatheter Tricuspid Valve Intervention Market - By Country, By Value (Year-2030)
Figure 48: Europe Transcatheter Tricuspid Valve Intervention Market - By Country Market Share, 2025 & 2030
Figure 49: Germany Transcatheter Tricuspid Valve Intervention Market Size, By Value, 2025-2030 (USD Million)
Figure 50: Germany Healthcare Industry Scenario (2016-2019)
Figure 51: Germany Population ages 65 and above (% of total Population), 2016-20
Figure 52: Germany Transcatheter Tricuspid Valve Intervention Market - By Intervention Type, By Value (USD Million), 2021-2030
Figure 53: Germany Transcatheter Tricuspid Valve Intervention Market - By Disease Type, By Value (USD Million), 2021-2030
Figure 54: Germany Transcatheter Tricuspid Valve Intervention Market - By End User, By Value (USD Million), 2021-2030
Figure 55: United Kingdom Transcatheter Tricuspid Valve Intervention Market Size, By Value, 2021-2030 (USD Million)
Figure 56: United Kingdom Current health expenditure per capita, PPP (current int. USD), 2014-18
Figure 57: United Kingdom Population ages 65 and above (% of total Population), 2016-20
Figure 58: United Kingdom Transcatheter Tricuspid Valve Intervention Market - By Intervention Type, By Value (USD Million), 2021-2030
Figure 59: United Kingdom Transcatheter Tricuspid Valve Intervention Market - By Disease Type, By Value (USD Million), 2021-2030
Figure 60: United Kingdom Transcatheter Tricuspid Valve Intervention Market - By End User, By Value (USD Million), 2021-2030
Figure 61: Italy Transcatheter Tricuspid Valve Intervention Market Size, By Value, 2021-2030 (USD Million)
Figure 62: Italy Current health expenditure per capita (current USD), 2014-18
Figure 63: Italy Population ages 65 and above (% of total Population), 2016-20
Figure 64: Italy Transcatheter Tricuspid Valve Intervention Market - By Intervention Type, By Value (USD Million), 2021-2030
Figure 65: Italy Transcatheter Tricuspid Valve Intervention Market - By Disease Type, By Value (USD Million), 2021-2030
Figure 66: Italy Transcatheter Tricuspid Valve Intervention Market - By End User, By Value (USD Million), 2021-2030
Figure 67: France Transcatheter Tricuspid Valve Intervention Market Size, By Value, 2021-2030 (USD Million)
Figure 68: France Current health expenditure per capita (current USD ), 2014-18
Figure 69: France Population ages 65 and above (% of total Population), 2016-20
Figure 70: France Transcatheter Tricuspid Valve Intervention Market - By Intervention Type, By Value (USD Million), 2021-2030
Figure 71: France Transcatheter Tricuspid Valve Intervention Market - By Disease Type, By Value (USD Million), 2021-2030
Figure 72: France Transcatheter Tricuspid Valve Intervention Market - By End User, By Value (USD Million), 2021-2030
Figure 73: Asia Pacific Transcatheter Tricuspid Valve Intervention Market Size, By Value, 2025-2030 (USD Million)
Figure 74: Asia Pacific, Current health expenditure per capita (current USD), 2014-18
Figure 75: Asia Pacific, Population ages 65 and above (% of total Population), 2016-20
Figure 76: Asia Pacific, Current health expenditure per capita, by countries (current USD), 2018
Figure 77: Asia Pacific Population ages 65 and above, by Countries (% of total Population), 2020
Figure 78: Asia Pacific Diabetes Prevalence, By Country, 2020 (% of Population Age 20 to 79)
Figure 79: Asia Pacific Transcatheter Tricuspid Valve Intervention Market - By Intervention Type, By Value (USD Million), 2021-2030
Figure 80: Asia Pacific Transcatheter Tricuspid Valve Intervention Market - By Disease Type, By Value (USD Million), 2021-2030
Figure 81: Asia Pacific Transcatheter Tricuspid Valve Intervention Market - By End User, By Value (USD Million), 2021-2030
Figure 82: Market Opportunity Chart of APAC Transcatheter Tricuspid Valve Intervention Market - By Country, By Value (Year-2026)
Figure 83: APAC Transcatheter Tricuspid Valve Intervention Market - By Country Market Share, 2025 & 2030
Figure 84: China Transcatheter Tricuspid Valve Intervention Market Size, By Value, 2021-2030 (USD Million)
Figure 85: China Current health expenditure per capita (current USD), 2014-18
Figure 86: China Population ages 65 and above (% of total Population), 2016-20
Figure 87: China Transcatheter Tricuspid Valve Intervention Market - By Intervention Type, By Value (USD Million), 2021-2030
Figure 88: China Transcatheter Tricuspid Valve Intervention Market - By Disease Type, By Value (USD Million), 2021-2030
Figure 89: China Transcatheter Tricuspid Valve Intervention Market - By End User, By Value (USD Million), 2021-2030
Figure 90: Japan Transcatheter Tricuspid Valve Intervention Market Size, By Value, 2021-2030 (USD Million)
Figure 91: Japan Healthcare Expenditure Outlook (%)
Figure 92: Japan Population ages 65 and above (% of total Population), 2016-20
Figure 93: Japan Transcatheter Tricuspid Valve Intervention Market - By Intervention Type, By Value (USD Million), 2021-2030
Figure 94: Japan Transcatheter Tricuspid Valve Intervention Market - By Disease Type, By Value (USD Million), 2021-2030
Figure 95: Japan Transcatheter Tricuspid Valve Intervention Market - By End User, By Value (USD Million), 2021-2030
Figure 96: India Transcatheter Tricuspid Valve Intervention Market Size, By Value, 2021-2030 (USD Million)
Figure 97: India Current health expenditure per capita (current USD), 2014-18
Figure 98: India Population ages 65 and above (% of total Population), 2016-20
Figure 99: India Transcatheter Tricuspid Valve Intervention Market - By Intervention Type, By Value (USD Million), 2021-2030
Figure 100: India Transcatheter Tricuspid Valve Intervention Market - By Disease Type, By Value (USD Million), 2021-2030
Figure 101: India Transcatheter Tricuspid Valve Intervention Market - By End User, By Value (USD Million), 2021-2030
Figure 102: Australia Transcatheter Tricuspid Valve Intervention Market Size, By Value, 2021-2030 (USD Million)
Figure 103: Australia Current health expenditure per capita (current USD), 2014-18
Figure 104: Australia Population ages 65 and above (% of total Population), 2016-20
Figure 105: Australia Transcatheter Tricuspid Valve Intervention Market - By Intervention Type, By Value (USD Million), 2021-2030
Figure 106: Australia Transcatheter Tricuspid Valve Intervention Market - By Disease Type, By Value (USD Million), 2021-2030
Figure 107: Australia Transcatheter Tricuspid Valve Intervention Market - By End User, By Value (USD Million), 2021-2030
Figure 108: Market Attractiveness Chart of Global Transcatheter Tricuspid Valve Intervention Market - By Intervention Type (Year-2030)
Figure 109: Market Attractiveness Chart of Global Transcatheter Tricuspid Valve Intervention Market - By Intervention Type (Year-2030)
Figure 110: Market Attractiveness Chart of Global Transcatheter Tricuspid Valve Disease Market - By End User (Year-2030)
Figure 111: Market Attractiveness Chart of Global Transcatheter Tricuspid Valve Intervention Market - By Region (Year-2030)
Figure 112: Edwards Lifesciences Annual Sales Revenue, 2021-2025 (USD Million)
Figure 113: Edwards Lifesciences Net Income, 2021-2025 (USD Million)
Figure 114: Edwards Lifesciences Sales Revenue, By Business Segment (%), FY2020
Figure 115: Edwards Lifesciences Sales Revenue, By Geographical Segment (%), FY2020
Figure 116: Abbott Laboratories Sales Revenue, 2021-2025 (USD Million)
Figure 117: Abbott Laboratories Net Income, 2021-2025 (USD Million)
Figure 118: Abbott Laboratories Sales Revenue, By Business Segment (%), FY2020
Figure 119: Abbott Laboratories Sales Revenue, By Geographical Segment (%), FY2020
Figure 120: Medtronic PLC Annual Sales Revenue, 2021-2025 (USD Million)
Figure 121: Medtronic PLC Net Income, 2021-2025 (USD Million)
Figure 122: Medtronic PLC Sales Revenue, By Business Segment (%), FY2020
Figure 123: Medtronic PLC Sales Revenue, By Geographical Segment (%), FY2020
Figure 124: LivaNova PLC Annual Sales Revenue, 2021-2025 (USD Million)
Figure 125: LivaNova PLC Net Income, 2021-2025 (USD Million)
Figure 126: LivaNova PLC Sales Revenue, By Business Segment (%), FY2020
Figure 127: LivaNova PLC Sales Revenue, By Geographical Segment (%), FY2020
Figure 128: CryoLife Annual Sales Revenue, 2021-2025 (USD Million)
Figure 129: CryoLife Net Income, 2021-2025 (USD Million)
Figure 130: CryoLife Sales Revenue, By Business Segment (%), FY2020
Figure 131: CryoLife Sales Revenue, By Geographical Segment (%), FY2020
Figure 132: Venus MedTech Annual Sales Revenue, 2021-2025 (USD Million)
Figure 133: Venus MedTech Net Income, 2021-2025 (USD Million)
Figure 134: Venus MedTech Sales Revenue, By Business Segment (%), FY2020
Figure 135: Venus MedTech Sales Revenue, By Geographical Segment (%), FY2020